HMC
KNTE
Harvard Management Company’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-462,418
| Closed | -$1.4M | – | 31 |
|
|
2023
Q2 | $1.4M | Sell |
462,418
-35,583
| -7% | -$108K | 0.14% | 23 |
|
|
2023
Q1 | $3.11M | Hold |
498,001
| – | – | 0.33% | 26 |
|
|
2022
Q4 | $3.04M | Hold |
498,001
| – | – | 0.38% | 28 |
|
|
2022
Q3 | $5.95M | Hold |
498,001
| – | – | 0.74% | 21 |
|
|
2022
Q2 | $6.28M | Hold |
498,001
| – | – | 0.73% | 22 |
|
|
2022
Q1 | $5.61M | Hold |
498,001
| – | – | 0.57% | 27 |
|
|
2021
Q4 | $8.83M | Hold |
498,001
| – | – | 0.83% | 22 |
|
|
2021
Q3 | $11.5M | Hold |
498,001
| – | – | 0.67% | 22 |
|
|
2021
Q2 | $11.6M | Hold |
498,001
| – | – | 0.67% | 22 |
|
|
2021
Q1 | $15.5M | Hold |
498,001
| – | – | 0.87% | 20 |
|
|
2020
Q4 | $19.8M | Buy |
+498,001
| New | +$19.8M | 1.07% | 13 |
|